(Q33898840)

29 July 2017

title

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models (English)

1 reference

29 July 2017

1 reference

7

Edina Sinanovic

0 references

Mark Jit

1

object named as

Mark Jit

1 reference

29 July 2017

Nadia Demarteau

2

1 reference

29 July 2017

Elamin Elbasha

3

1 reference

29 July 2017

Gary Ginsberg

4

1 reference

29 July 2017

Jane Kim

5

1 reference

29 July 2017

Naiyana Praditsitthikorn

6

1 reference

29 July 2017

Raymond Hutubessy

8

1 reference

29 July 2017

language of work or name

English

0 references

publication date

12 May 2011

1 reference

29 July 2017

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

page(s)

54

1 reference

https://scigraph.springernature.com/pub.10.1186/1741-7015-9-54

29 July 2017

exact match

0 references

cites work

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

A brief history of economic evaluation for human papillomavirus vaccination policy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Economic evaluation of human papillomavirus vaccination in developed countries

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Evolution of the health economics of cervical cancer vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Modeling cervical cancer prevention in developed countries

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Structural differences among cost-effectiveness models of human papillomavirus vaccines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Cost-effectiveness analyses of human papillomavirus vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Model for assessing human papillomavirus vaccination strategies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

Epidemiologic classification of human papillomavirus types associated with cervical cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3123559

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa.

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1741-7015-9-54

Human papillomavirus vaccines. WHO position paper

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21569406

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prophylactic HPV vaccination for women over 18 years of age

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21569406

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-9-54

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference